LRRC70

gene
On this page

Also known as SLRNLOC100130733

Summary

LRRC70 (leucine rich repeat containing 70, HGNC:35155) is a protein-coding gene on chromosome 5q12.1, encoding Leucine-rich repeat-containing protein 70 (Q7Z2Q7). Renders cells highly sensitive to the activation by cytokines and lipopolysaccharide (LPS).

Involved in positive regulation of response to cytokine stimulus. Located in plasma membrane.

Source: NCBI Gene 100130733 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 1 total
  • MANE Select transcript: NM_181506

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:35155
Approved symbolLRRC70
Nameleucine rich repeat containing 70
Location5q12.1
Locus typegene with protein product
StatusApproved
AliasesSLRN, LOC100130733
Ensembl geneENSG00000186105
Ensembl biotypeprotein_coding
Entrez100130733

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000334994, ENST00000448151, ENST00000491184

RefSeq mRNA: 1 — MANE Select: NM_181506 NM_181506

CCDS: CCDS47218

Canonical transcript exons

ENST00000334994 — 2 exons

ExonStartEnd
ENSE000013379916257940162581446
ENSE000016744726257881962578935

Expression profiles

Bgee: expression breadth ubiquitous, 133 present calls, max score 83.26.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0250 / max 4.8754, expressed in 8 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
566482.7318376
566490.02508

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.26gold quality
subcutaneous adipose tissueUBERON:000219080.20gold quality
adipose tissueUBERON:000101380.08gold quality
omental fat padUBERON:001041479.94gold quality
smooth muscle tissueUBERON:000113578.53gold quality
thoracic mammary glandUBERON:000520078.27gold quality
spleenUBERON:000210677.57gold quality
gall bladderUBERON:000211077.23gold quality
left uterine tubeUBERON:000130375.80gold quality
thyroid glandUBERON:000204675.36gold quality
left lobe of thyroid glandUBERON:000112074.83gold quality
calcaneal tendonUBERON:000370174.71gold quality
right lobe of thyroid glandUBERON:000111974.40gold quality
placentaUBERON:000198774.39gold quality
myometriumUBERON:000129673.19gold quality
tibial nerveUBERON:000132373.18gold quality
ectocervixUBERON:001224973.13gold quality
endocervixUBERON:000045873.08gold quality
body of uterusUBERON:000985372.94gold quality
bloodUBERON:000017872.16gold quality
skin of abdomenUBERON:000141671.78gold quality
mucosa of stomachUBERON:000119971.65gold quality
left coronary arteryUBERON:000162671.41gold quality
vaginaUBERON:000099671.35gold quality
olfactory segment of nasal mucosaUBERON:000538671.28gold quality
uterine cervixUBERON:000000271.21gold quality
zone of skinUBERON:000001471.21gold quality
fallopian tubeUBERON:000388971.20gold quality
skin of legUBERON:000151171.10gold quality
tibial arteryUBERON:000761071.05gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-100618yes453.37
E-ANND-3yes2.98
E-MTAB-6678no3.05

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • Synleurin, a novel leucine-rich repeat protein that increases the intensity of pleiotropic cytokine and growth factor responses. (PMID:12767927)

Cross-species orthologs

0 orthologs

Paralogs (25): SLITRK3 (ENSG00000121871), LRFN3 (ENSG00000126243), LRFN1 (ENSG00000128011), SLIT2 (ENSG00000145147), LRFN2 (ENSG00000156564), LRRC38 (ENSG00000162494), SLITRK5 (ENSG00000165300), LRFN5 (ENSG00000165379), LRTM2 (ENSG00000166159), LINGO1 (ENSG00000169783), LRRN2 (ENSG00000170382), LRRN3 (ENSG00000173114), LRFN4 (ENSG00000173621), LINGO2 (ENSG00000174482), LRRN1 (ENSG00000175928), SLITRK1 (ENSG00000178235), GP5 (ENSG00000178732), SLITRK4 (ENSG00000179542), LRRC55 (ENSG00000183908), SLIT3 (ENSG00000184347), SLITRK6 (ENSG00000184564), SLITRK2 (ENSG00000185985), SLIT1 (ENSG00000187122), TLR9 (ENSG00000239732), TPBGL (ENSG00000261594)

Protein

Protein identifiers

Leucine-rich repeat-containing protein 70Q7Z2Q7 (reviewed: Q7Z2Q7)

Alternative names: Synleurin

All UniProt accessions (2): Q7Z2Q7, D6RD14

UniProt curated annotations — full annotation on UniProt →

Function. Renders cells highly sensitive to the activation by cytokines and lipopolysaccharide (LPS).

Subcellular location. Membrane.

Tissue specificity. Expressed at low levels in many tissues, including smooth muscle, brain, uterus, pancreas, cartilage, adipose, spleen and testis.

RefSeq proteins (1): NP_852607* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000483Cys-rich_flank_reg_CDomain
IPR001611Leu-rich_rptRepeat
IPR003591Leu-rich_rpt_typical-subtypRepeat
IPR026906LRR_5Repeat
IPR032675LRR_dom_sfHomologous_superfamily
IPR050328Dev_Immune_ReceptorFamily

Pfam: PF13306, PF13855

UniProt features (22 total): repeat 12, glycosylation site 4, domain 2, signal peptide 1, chain 1, transmembrane region 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7Z2Q7-F173.990.53

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (4): 215, 266, 331, 400

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 20 (showing top): GOBP_RESPONSE_TO_PEPTIDE, GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS, chr5q12, GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS, MIR548L, MIR6891_5P, MIR12118, MIR3173_3P, DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS, DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS, DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS, NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE, HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_UP, HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN, TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL

GO Biological Process (1): positive regulation of response to cytokine stimulus (GO:0060760)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
response to cytokine1
positive regulation of response to stimulus1
regulation of response to cytokine stimulus1
binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

398 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LRRC70IPO11Q9UI26847
LRRC70RPL12P30050762
LRRC70IPO5O00410712
LRRC70RPL23AP29316712
LRRC70UBE2E3Q969T4501
LRRC70OR1B1Q8NGR6474
LRRC70PDGFBP01127453
LRRC70CNPPD1Q9BV87434
LRRC70FGF13Q92913402
LRRC70INAVAQ3KP66398
LRRC70WFDC12Q8WWY7370
LRRC70IGF2P01344365
LRRC70FGF2P09038358
LRRC70WFDC5Q8TCV5348
LRRC70ZNF415Q09FC8348

IntAct

2 interactions, top by confidence:

ABTypeScore
LRRC70H2BC9psi-mi:“MI:0915”(physical association)0.400

BioGRID (3): LRRC70 (Affinity Capture-MS), HIST1H2BH (Proximity Label-MS), LRRC70 (Proximity Label-MS)

ESM2 similar proteins: A4D1F6, A4IIK1, A6H6A4, A6NIV6, A6NM36, C0STK7, D3ZXS4, F1R6I3, F6R2G2, P14605, Q09562, Q32KX5, Q38SD2, Q3TX51, Q3UHC2, Q3UV48, Q3ZC49, Q4R6F0, Q54AX5, Q58A48, Q5G5E0, Q62192, Q65YW8, Q65Z91, Q66HD6, Q6AXL3, Q6GLE8, Q6GM71, Q6R5N8, Q6ZNQ3, Q7Z2Q7, Q86X40, Q8BGI7, Q8C0R9, Q8N456, Q8VDB8, Q96DD0, Q99467, Q99MB1, Q9BYS8

Diamond homologs: A8WGA3, B1H134, B1H234, D3ZTV3, D4ABX8, F1NUK7, G5EFX6, O42235, O43155, O55226, O60938, O75093, O88279, O88280, O94769, O94991, P04629, P13224, P14770, P24014, P50608, P50609, P56400, P59383, P83503, Q04785, Q06828, Q3UHC2, Q5R6T0, Q5RAC4, Q5RI43, Q6RKD8, Q6WRH9, Q70AK3, Q7Z2Q7, Q80TR4, Q80XU8, Q810B7, Q810C1, Q8BGT1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

192 predictions. Top by Δscore:

VariantEffectΔscore
5:62578903:C:Gdonor_gain0.9900
5:62579399:A:AGacceptor_gain0.9800
5:62579400:G:GGacceptor_gain0.9800
5:62579400:GCCA:Gacceptor_gain0.9800
5:62579617:A:Tdonor_gain0.9800
5:62579485:T:TAdonor_gain0.9600
5:62578853:T:Gdonor_gain0.9500
5:62579622:AC:Adonor_gain0.9500
5:62579398:T:Gacceptor_gain0.9400
5:62579400:GC:Gacceptor_gain0.9300
5:62579400:GCC:Gacceptor_gain0.9000
5:62579486:T:TAdonor_gain0.9000
5:62578931:TCTTG:Tdonor_loss0.8900
5:62578932:CTTGG:Cdonor_loss0.8900
5:62578933:TTG:Tdonor_loss0.8900
5:62578934:TGGT:Tdonor_loss0.8900
5:62578935:GGTAA:Gdonor_loss0.8900
5:62578936:GT:Gdonor_loss0.8900
5:62578937:TAAGA:Tdonor_loss0.8900
5:62578938:A:Cdonor_loss0.8700
5:62578936:G:GGdonor_gain0.8500
5:62579488:T:Gdonor_gain0.8400
5:62579619:A:AGdonor_gain0.8400
5:62579620:G:GGdonor_gain0.8400
5:62578850:GAGT:Gdonor_gain0.8200
5:62579397:ATAGC:Aacceptor_loss0.7900
5:62579398:TA:Tacceptor_loss0.7900
5:62579399:A:ACacceptor_loss0.7900
5:62579400:G:Aacceptor_loss0.7900
5:62579400:GCCAA:Gacceptor_gain0.7900

AlphaMissense

4058 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:62580519:T:AW361R0.991
5:62580519:T:CW361R0.991
5:62580521:G:CW361C0.987
5:62580521:G:TW361C0.987
5:62580427:T:CL330P0.980
5:62580433:T:CL332P0.975
5:62580427:T:AL330H0.971
5:62580352:T:CL305P0.970
5:62580136:T:CL233P0.969
5:62580064:T:CL209S0.967
5:62580443:T:AN335K0.967
5:62580443:T:GN335K0.967
5:62579920:T:CL161S0.966
5:62579926:T:CL163P0.965
5:62579992:T:AL185H0.965
5:62580208:T:CL257P0.964
5:62580433:T:AL332Q0.964
5:62580499:T:CL354P0.964
5:62580515:T:AN359K0.964
5:62580515:T:GN359K0.964
5:62580525:T:AC363S0.964
5:62580525:T:CC363R0.964
5:62580526:G:CC363S0.964
5:62579792:T:AN118K0.963
5:62579792:T:GN118K0.963
5:62580085:T:CL216S0.963
5:62580136:T:AL233H0.962
5:62580433:T:GL332R0.961
5:62579998:T:CL187S0.960
5:62581053:T:CC539R0.960

dbSNP variants (sampled 300 via entrez): RS1000732389 (5:62581740 GA>G,GAA), RS1001633149 (5:62578815 T>G), RS1002072423 (5:62578813 G>A), RS1002132219 (5:62580627 C>T), RS1003388292 (5:62579234 C>A), RS1004602264 (5:62580255 A>C,G,T), RS1005105011 (5:62577300 C>T), RS1005659200 (5:62580508 A>G), RS1006316409 (5:62578316 T>A), RS10066921 (5:62578802 A>C), RS1007159621 (5:62580300 T>A,G), RS1007497172 (5:62579951 T>C), RS1007910425 (5:62581911 C>T), RS1008116532 (5:62578919 C>T), RS1009430946 (5:62579618 A>G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST007324_14Adventurousness1.000000e-10

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0008579risk-taking behaviour

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression2
aristolochic acid Iincreases expression1
methylmercuric chloridedecreases expression1
bisphenol Aaffects expression1
2-butenalincreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
abrineincreases expression1
Diethylhexyl Phthalatedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.